03/30/2020 |
 |
| Steven Carr of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and the Broad Institute of Harvard and MIT in Cambridge, Massachusetts discusses post-translational modifications. proteomics.cancer.gov/about/ |
Orphanet Journal of Rare Diseases
Hace 5 horas
No hay comentarios:
Publicar un comentario